Provided by Tiger Trade Technology Pte. Ltd.

Medicus Pharma Ltd.

0.0921
-0.0098-9.62%
Post-market: 0.0845-0.0076-8.25%19:48 EDT
Volume:17.32M
Turnover:1.77M
Market Cap:5.82M
PE:-0.06
High:0.0948
Open:0.0865
Low:0.0840
Close:0.1019
52wk High:2.78
52wk Low:0.0840
Shares:63.18M
Float Shares:46.69M
Volume Ratio:3.74
T/O Rate:37.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6597
EPS(LYR):-2.7356
ROE:-7446.11%
ROA:-110.67%
PB:-3.30
PE(LYR):-0.03

Loading ...

Medicus reports positive dose-response in Phase 2 SkinJect trial for basal cell carcinoma

Reuters
·
May 06

Medicus Pharma Ltd - Announces Positive Dose Response in Phase 2 Sknjct-003 Study for Bcc

THOMSON REUTERS
·
May 06

Medicus Pharma Ltd - D-Mna Shows Favorable Safety Profile With No Drug-Related Serious Adverse Events

THOMSON REUTERS
·
May 06

Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response

GlobeNewswire
·
May 06

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill

GlobeNewswire
·
Apr 27

Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines

TIPRANKS
·
Apr 25

Medicus Pharma Expands ATM Equity Program for Funding

TIPRANKS
·
Apr 25

BRIEF-Medicus Pharma Ltd May Offer And Sell Common Shares Up To $50 Million Aggregate Through Agents

Reuters
·
Apr 24

Medicus Pharma Ltd - May Offer and Sell Common Shares up to $50 Mln Aggregate Through Agents - SEC Filing

THOMSON REUTERS
·
Apr 24

Medicus Pharma initiated with a Buy at Roth Capital

TIPRANKS
·
Apr 21

Medicus Pharma announces annual general and special shareholder meeting

Reuters
·
Apr 21

Medicus Pharma Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 20

Medicus Pharma submits ODD application to U.S. FDA for SkinJect

TIPRANKS
·
Apr 17

Medicus Pharma seeks FDA orphan drug designation for SkinJect in Gorlin syndrome

Reuters
·
Apr 17

Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy

TIPRANKS
·
Apr 15

EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline

Benzinga_recent_news
·
Apr 15